Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel (opens in a new tab)
Active, not recruitingPhase 2/3
DocetaxelBicalutamideDegarelix
Dr. Robert E. Reilly, DO
NPI1124178819PAC ID6406945351
- Medicare services, 2024
- 46,633
- Medicare patients, 2024
- 580
- Part D claims, 2024
- 1,131
- Clinical trials
- 8
- MIPS score, 2024
- 75
- Practice address
- 915 Lawn Ave, Sellersville, PA 18960
- Practice phone
- Call (215) 257-3697
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Pennridge Surgical Associates
Sellersville, Pennsylvania
Find Dr. Reilly's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robert E. Reilly is a hematologist and oncologist in Sellersville, Pennsylvania
Dr. Reilly practices at Pennridge Surgical Associates in Sellersville, Pennsylvania.
Dr. Reilly's NPI, 1124178819, was assigned on January 12, 2007. Dr. Reilly graduated from New York College of Osteo Medicine of New York Institute of Technology in 1981. Dr. Reilly holds Pennsylvania license OS005276L.
NPI and contact details
- NPI
- 1124178819NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6406945351
- NPI enumeration date
- January 12, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (215) 257-3697
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Robert E. Reilly practices at Pennridge Surgical Associates in Sellersville, Pennsylvania
Dr. Reilly's primary practice is Pennridge Surgical Associates, at 915 Lawn Ave, Sellersville, PA 18960 in Bucks County. The practice phone is (215) 257-3697.
- Pennridge Surgical Associates915 Lawn Ave, Sellersville, PA 18960 · Bucks CountyPhone(215) 257-3697
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Robert E. Reilly is affiliated with 7 sites of care and 2 medical groups
Dr. Reilly's primary practice is Pennridge Surgical Associates in Sellersville, Pennsylvania. Dr. Reilly is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Alliance Cancer Specialists. Dmand AI also links Dr. Reilly to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Pennridge Surgical AssociatesPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Robert E. Reilly's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reilly practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Pennridge Surgical Associates | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Reilly practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robert E. Reilly is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Reilly's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Reilly is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Reilly
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robert E. Reilly billed Medicare for 46,633 services in 2024
CMS data shows 46,633 Medicare services from Dr. Reilly across 34 procedure codes in 2024, for 580 Medicare patients. Medicare paid $530,188 for them.
Medicare services, 202446,633
Medicare patients580
Paid by Medicare$530,188
Procedure codes34
Dr. Reilly's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 44,8182024: 37,15617%
- Other services
- 2023: 02024: 4,411
- Tests and treatments
- 2023: 1,4062024: 1,54910%
- Surgery
- 2023: 9762024: 1,34238%
- Office and hospital visits
- 2023: 1,4042024: 1,23012%
- Lab and pathology
- 2023: 1,3622024: 94531%
Where Dr. Reilly's Medicare services took place, 2024
- In an office46,537100%
- In a facility960%
Dr. Reilly compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Reilly
- Pennsylvania median
- Medicare services
- 46,633vs 65471.3 times
- Medicare patients
- 580vs 2272.6 times
- Part D claims
- 844vs 3932.1 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Reilly's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Reilly?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reilly and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Robert E. Reilly treated 580 Medicare patients in 2024, average age 75
CMS counts 580 Medicare patients who saw Dr. Reilly in 2024. The largest group is 75 to 84, with 255 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Reilly's median patient age at 73, with 70% women.
Medicare patients, 2024580
Average age75
Average risk score1.76
Also on Medicaid7%
Dr. Reilly's Medicare patients by age, 2024
Dr. Reilly's Medicare patients by sex, 2024
- Women40670%
- Men17430%
Chronic conditions among Dr. Reilly's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer58%
- Arthritis49%
- Ischemic heart disease39%
- Diabetes34%
- Anxiety32%
- Mood disorders27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Reilly's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women70%
- Men27%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Robert E. Reilly wrote 1,131 Medicare Part D claims in 2024
In 2024, Dr. Reilly wrote 1,131 Medicare Part D claims for 257 patients. 77% of them were for generic drugs. CMS names the drug for 844 of them, across 21 drugs with 11 or more claims each, at $696,848 in total drug cost. In 2023, CMS named 840 claims across 18 drugs.
Part D claims, 20241,131
Drugs named by CMS21
Total drug cost$696,848
Part D patients257
Dr. Reilly's Part D claims by kind of drug, 2024
- Generic874 claims77%
- Brand-name257 claims23%
Dr. Reilly's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Reilly's Part D claims, 2024
- Opioids3%37 of 1,131 claims
- Antibiotics1%14 of 1,131 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8402024: 844No change
Drugs named by CMS: 21 in 2024, 18 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Robert E. Reilly scored 75 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Reilly for performance year 2024. Dr. Reilly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
- MIPS final score, 2024
- 75 of 100
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Reilly by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robert E. Reilly has worked on 8 clinical trials
Dmand AI links Dr. Reilly to 8 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Diseases. Agendia sponsors the most, 2.
Clinical trials with Dr. Reilly by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Reilly's trials
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Reilly
- John D. Ayers, MD3 shared trials
- Mary Dickinson Chamberlin, MD3 shared trials
- Steven William Corso, MD3 shared trials
Recent clinical trials with Dr. Reilly
Breast NeoplasmsBreast Diseases
Breast Cancer WEight Loss Study (BWEL Study) (opens in a new tab)
Active, not recruitingPhase 3
Breast NeoplasmsBreast Diseases
Breast NeoplasmsBreast Diseases
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Robert E. Reilly received $20,937 in industry payments from 2016 to 2025
CMS Open Payments shows 1,074 general payments to Dr. Reilly from 82 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,700.
General payments to Dr. Reilly by program year, 2016 to 2025
General payments to Dr. Reilly by kind, 2016 to 2025
$20.9Kin total
- Food and beverage$20,75799%
- Education$1791%
Companies that paid Dr. Reilly the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Robert E. Reilly graduated from New York College of Osteo Medicine of New York Institute of Technology
Dr. Reilly graduated from New York College of Osteo Medicine of New York Institute of Technology in 1981.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Robert E. Reilly's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robert E. Reilly
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robert E. Reilly's NPI number?
Dr. Robert E. Reilly's NPI number is 1124178819. It was assigned on January 12, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Robert E. Reilly?
Dr. Robert E. Reilly is a hematologist and oncologist in Sellersville, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Robert E. Reilly practice?
Dr. Reilly practices at 915 Lawn Ave, Sellersville, PA 18960. Dr. Reilly's primary practice is Pennridge Surgical Associates in Sellersville, Pennsylvania. Dmand AI also links Dr. Reilly to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Robert E. Reilly's office phone number?
The practice phone on file for Dr. Reilly is (215) 257-3697.
What is Dr. Robert E. Reilly's medical license number?
Dr. Reilly holds Pennsylvania license OS005276L.
Which hospitals is Dr. Robert E. Reilly affiliated with?
Dr. Reilly is affiliated with Hospital of the University of Pennsylvania. Dmand AI links Dr. Reilly to 3 more hospitals.
What medical group is Dr. Robert E. Reilly part of?
Dr. Reilly is linked to Alliance Cancer Specialists. Dmand AI links Dr. Reilly to 1 more medical group.
Does Dr. Robert E. Reilly accept Medicare?
Yes. CMS data shows Dr. Reilly billed Medicare for 46,633 services in 2024, and Dr. Reilly accepts Medicare assignment.
What is Dr. Robert E. Reilly's MIPS score?
Dr. Reilly's MIPS final score for performance year 2024 is 75 out of 100.
How many Medicare patients does Dr. Robert E. Reilly see?
CMS counts 580 Medicare patients who saw Dr. Reilly in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Robert E. Reilly bill to Medicare?
In 2024, Dr. Reilly's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J1453) and injected or infused drug (J0897).
Where did Dr. Robert E. Reilly go to medical school?
Dr. Reilly graduated from New York College of Osteo Medicine of New York Institute of Technology in 1981.
What drugs does Dr. Robert E. Reilly prescribe most?
In 2024 Medicare Part D data, Dr. Reilly's most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Eliquis.
Has Dr. Robert E. Reilly received payments from drug or device companies?
CMS Open Payments shows $20,937 in general payments to Dr. Reilly from 82 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Robert E. Reilly been practicing?
Dr. Reilly graduated from medical school in 1981, 45 years ago.
Does Dr. Robert E. Reilly do research?
Dr. Reilly has worked on 8 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card